Results 141 to 150 of about 387,299 (303)

Pharmacological effects of gastrodin: Insight into neurological diseases and mechanism in ferroptosis and pyroptosis

Ibrain, Volume 11, Issue 1, Page 74-83, Spring 2025.
Pharmacological effects of gastrodin include prevention and treatment of cognitive decline and reperfusion injuries, anticonvulsion, antiepilepsy, antidepressants, and analgesia, which are related to antiferroptosis and antipyroptosis. Abstract Gastrodin, as an effective monomer of gastrodia elata, plays a significant role in anti‐inflammatory ...
Xue Zheng, Jing Li, Zhao‐Qiong Zhu
wiley   +1 more source

Other title: Rules and Regulations Relating to Alcoholic Liquor

, 1949
Issued by: State Director of Alcoholic Beverage Control, 1949-1968; Division of Alcoholic Beverage Control, Kansas Department of Revenue, 1973 ...
Kansas. Division of Alcoholic Beverage Control
core   +1 more source

Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mouse

, 2023
Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in ...
L Leybaert (13303389), B Cogliati (13303395), M Maes (13303332), S C Yanguas (13303380), R M Rodrigues (13303383), M Vinken (13303398), I Leclercq (13303392), V M Govoni (13303377), T C da Silva (13303374), J Willebrords (13303368), E Decrock (13303386), I V A Pereira (13303371)   +11 more
core  

Surgically confirmed severe endometriosis is associated with lower risk of steatotic liver disease: Evidence of estrogen‐linked hepatic–reproductive crosstalk

International Journal of Gynecology &Obstetrics, EarlyView.
Severe surgically confirmed endometriosis was associated with a lower prevalence of steatotic liver disease than non‐severe disease. Higher estradiol levels may partly explain this inverse hepatic–reproductive association, supporting integrated gynecologic and hepatologic risk assessment.
Jung Hyun Park, Keungmo Yang, Hyun Yang, Si Hyun Bae, Mee‐Ran Kim, Jaejun Lee   +5 more
wiley   +1 more source

Rutin Attenuates Non-Alcoholic Steatohepatitis in High Carbohydrate-High Fat Diet-Fed Rats

, 2011
Background and Aims: Non-alcoholic fatty liver disease (NAFLD) is frequently associated with the signs of metabolic syndrome, especially obesity, dyslipidaemia and insulin resistance.
Arumugam, T. V., Panchal, SK, Poudyal, H, Poudyal, Hemant, H. Poudyal, Panchal, Sunil K. (R20071), S.K. Panchal, Arumugam, TV, Arumugam, Thiruma V., L. Brown, Panchal, S. K., Brown, Lindsay, Poudyal, H., T.V. Arumugam, Brown, L., Brown, L   +15 more
core   +1 more source

Human biomarker navigator

iMeta, EarlyView.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li, Qian Zhang, Zijie Wang, Zeping Gui, Jing Liu, Jingda Li, Maojun Jiang, Zukang Chang, Qingqing Han, Bendong Yang, Tariq Saeed, Jun Li, Jinghan Jia, Chenghu Song, Tong Shao, Tianhuan Peng, Xueying Zhang, Pingping Guo, Jun Luo, Gangao Yang, Yuan Wan, Gokhan Zengin, Quan Yuan, Lingru Li, Xiaohui Fan, Yang Luo, Lvyun Zhu, Yanfei Zheng, Wenjun Mao, Wenlong Sun   +29 more
wiley   +1 more source

Exploring the Multifaceted Landscape of MASLD: A Comprehensive Synthesis of Recent Studies, from Pathophysiology to Organoids and Beyond

Biomedicines
Non-alcoholic fatty liver disease (NAFLD) is a widespread contributor to chronic liver disease globally. A recent consensus on renaming liver disease was established, and metabolic dysfunction-associated steatotic liver disease, MASLD, was chosen as the ...
Allison Soto, Colby Spongberg, Alessandro Martinino, Francesco Giovinazzo   +3 more
doaj   +1 more source

Ipragliflozin ameliorates liver damage in non-alcoholic fatty liver disease

Open Medicine, 2018
There are few effective medications for non-alcoholic steatohepatitis (NASH). We investigated the efficacy of ipragliflozin (selective sodium-glucose cotransporter-2 inhibitor [SGLT2I]) for the treatment of patients with type 2 diabetes mellitus (T2DM ...
Miyake Teruki, Yoshida Sakiko, Furukawa Shinya, Sakai Takenori, Tada Fujimasa, Senba Hidenori, Yamamoto Shin, Koizumi Yohei, Yoshida Osamu, Hirooka Masashi, Kumagi Teru, Niiya Tetsuju, Miyaoka Hiroaki, Masanori Abe, Matsuura Bunzo, Hiasa Yoichi   +15 more
doaj   +1 more source

Gut Enterococcus faecium derived leucic acid mediates the antiobesity effect of dietary fiber

iMeta, EarlyView.
This study identified Enterococcus faecium as a gut bacterium with anti‐obesity activity, which alleviated adipocyte hypertrophy, dyslipidemia, and hepatic steatosis by converting leucine into leucic acid (LEA) to regulate mitochondrial oxidative phosphorylation.
Baifei Hu, Qianru Gao, Junmin Hui, Mengqiong Wang, Haiyan Gao, Kai Li, Junping Zheng, Zhe Dai, Songlin Liu, Hongtao Liu   +9 more
wiley   +1 more source

Probiotics and intestinal permeability in adults with metabolic dysfunction‐associated steatohepatitis: A secondary analysis of a randomized clinical trial

Journal of Parenteral and Enteral Nutrition, EarlyView.
Abstract Background Metabolic dysfunction‐associated steatohepatitis (MASH) is associated with altered intestinal permeability, allowing microbial products to translocate to the liver via the enterohepatic circulation and contributes to disease progression. The aim of our study was to evaluate the association between probiotic supplementation and serum
Bruna Concheski de Moura, Samanta Catherine Ferreira, Amanda Souza Silva‐Sperb, Helena Abadie Moraes, Larisse Longo, Carolina Uribe‐Cruz, Matheus Truccolo Michalczuk, Themis Reverbel da Silveira, Carlos Thadeu Schmidt Cerski, Mário Reis Álvares da Silva, Valesca Dall'Alba   +10 more
wiley   +1 more source